1. Home
  2. LFMDP vs WGSWW Comparison

LFMDP vs WGSWW Comparison

Compare LFMDP & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeMD Inc.

LFMDP

LifeMD Inc.

N/A

Current Price

$22.78

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Logo GeneDx Holdings Corp.

WGSWW

GeneDx Holdings Corp.

HOLD

Current Price

$0.01

Market Cap

0.0

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFMDP
WGSWW
Founded
N/A
2017
Country
United States
United States
Employees
336
1300
Industry
Medical/Nursing Services
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LFMDP
WGSWW
Price
$22.78
$0.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.5K
62.5K
Earning Date
N/A
02-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$305,450,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
50.79
52 Week Low
$18.50
$0.01
52 Week High
$26.99
$0.25

Technical Indicators

Market Signals
Indicator
LFMDP
WGSWW
Relative Strength Index (RSI) 52.70 33.30
Support Level $22.03 $0.01
Resistance Level $22.84 $0.02
Average True Range (ATR) 0.21 0.00
MACD 0.02 0.00
Stochastic Oscillator 47.78 18.24

Price Performance

Historical Comparison
LFMDP
WGSWW

About LFMDP LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: